Venetoclax, Rituximab and Nivolumab in Combination for the Treatment of Richter's Transformation Arising From Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Clinical trial NCT06247540 · WITHDRAWN

Trial details

NCT number: NCT06247540
Sponsor: Northwestern University
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Transformed Chronic Lymphocytic Leukemia Refractory Transformed Chronic Lymphocytic Leukemia Richter Syndrome Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma

Start date: 2024-03-29
Primary completion: 2029-12-29
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.